Novel Shoe Device NUSHU to Measure Gait Analysis in Parkinson's Patients

Not Applicable

Not yet recruiting

• Conditions: Parkinson's Disease (PD)

• Registration Number: NCT06975059
• Lead Sponsor: Weill Medical College of Cornell University

Brief Summary

Gait changes in Parkinson's disease are complex, variable, and difficult to detect during short clinic assessments. The aim of this study is to collect gait measurements in Parkinson's patients through sensors in a novel shoe device, NUSHU by Magnes AG. The shoe additionally provides vibrational feedback that can potentially help gait difficulties experienced by Parkinson's patients.

Detailed Description

Not available

Study Timeline

• Status Verified: 2025-05
• Study First Submitted: 2025-05-08
• Study First Submitted QC: 2025-05-08
• Last Update Submitted: 2025-05-08
• Study First Posted: 2025-05-16
• Last Update Posted: 2025-05-16
• Study Start: 2025-07
• Primary Completion: 2027-07
• Study Completion: 2030-07

Recruitment & Eligibility

• Status: NOT_YET_RECRUITING
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

1. Male or female ≥ 18 years of age.
2. A diagnosis of Parkinson's disease
3. Able to give written informed consent (as determined by the investigator)
4. Can converse in English and read and perform all study activities
5. Has willingness and ability to comply with study requirements

Exclusion Criteria

1. Diagnosis of an atypical parkinsonism syndrome, drug-induced parkinsonism, essential tremor, or other diagnoses that explain movement symptoms other than PD
2. A diagnosis of significant CNS disease other than PD such as stroke, multiple sclerosis, epilepsy
3. Persons with disorders other than PD significantly affecting gait as determined by the investigator
4. History of MRI brain scan indicative of clinically significant abnormality as determined by the investigator
5. Inability to wear interventional device
6. Unable to ambulate independently at least with assistive walking device but without additional person assistance
7. Pregnant or planning pregnancy within study timeframe
8. Montreal Cognitive Assessment (MoCA) score < 22 at screening
9. Resides in a nursing home or assisted care facility

Healthy Controls:

Inclusion Criteria:

1. Male or female ≥ 18 years of age.
2. No neurological disease or other significant gait impairment as deemed by the study investigator

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Mean Score of Comfort Level of Device in Satisfaction Survey	At Safety Follow Up (Week 18)	The satisfaction survey contains 2 demographic questions and 5 questions about participant satisfaction completed at end of study participation. The comfort level of the device question is the following: How would you rate the comfort level of the device? The scale is 0, 1, 2, 3, 4, 5, with 0 meaning most uncomfortable and 5 meaning most comfortable. Mean score for each individual question will be provided.
Mean Score of Ease of Using Device in Satisfaction Survey	At Safety Follow Up (Week 18)	The satisfaction survey contains 2 demographic questions and 5 questions about participant satisfaction completed at end of study participation. The comfort level of the device question is the following: How easy was it to use the device? The scale is 0, 1, 2, 3, 4, 5, with 0 meaning very easy and 5 meaning very difficult. Mean score for each individual question will be provided.
Ratio of Participants Who Completed Study to Total Number of Participants Enrolled	Through study completion, 18 weeks	We would like to measure the retention rate to assess feasibility. The lowest ratio would be 0, and the highest ratio would be 1.

Secondary Outcome Measures

Name	Time	Method
Mean Change from Baseline to Week 12 in TUG test	At Baseline and In 12 Weeks	Timed Up and Go test assesses mobility, balance, walking ability, and fall risk in older adults by measuring how quickly the patient can stand up, walk 10 feet, turn around, walk back, and sit down. The score is the amount of time taken in seconds. There is no highest nor lowest score. The higher the time, the more problems the patient has with gait and requires gait aid.
Mean Change from Baseline to Week 12 in FOG Questionnaire	At Baseline and In 12 Weeks	Freezing of Gait questionnaire assesses FOG severity unrelated to falls, FOG frequency, gait disturbances, and relationship to clinical features associated with gait and motor aspects in Parkinson's patients. The score ranges from 0 to 24, and high scores correspond to more severe FOG.
Mean Change from Baseline to Week 12 in MDS-UPDRS III	At Baseline and In 12 Weeks	The Movement Disorder Society (MDS)-Unified Parkinson's Disease Rating Scale (UPDRS) Part III (motor examination; to be completed in the on-medication state) has instructions for the rater to give or demonstrate to the participant; it is completed by the investigator. Each question has a 0-4 rating scale. The total scores range from 0 to 132, with higher scores indicate increased severity.
Mean Change from Baseline to Week 12 in Stride Time	At Baseline and In 12 Weeks	The NUSHU shoe measures the stride time: the time elapsed between the first contact of two consecutive footsteps of the same foot. This time is collected in seconds.
Mean Change from Baseline to Week 12 in Stride Length	At Baseline and In 12 Weeks	The NUSHU shoe measures the stride length: the distance covered between the same spot where one foot hits the ground and the next time the same foot hits the ground again. This distance is collected in meters.
Mean Change from Baseline to Week 12 in Swing Time	At Baseline and In 12 Weeks	The NUSHU shoes measure the swing time: the amount of time the foot spends off the ground in the gait cycle, defined by the time from toe off to heel strike of the same foot. The time is collected in seconds.
Mean Change from Baseline to Week 12 in Stance Time	At Baseline and In 12 Weeks	The NUSHU shoes measure the stance time: the duration of the time between heel strike and toe off of the same foot. This time is collected in seconds.
Mean Change from Baseline to Week 12 in Velocity	At Baseline and In 12 Weeks	The NUSHU shoes measure the velocity: mean in-plane velocity of each gait cycle (m/s).
Mean Change from Baseline to Week 12 in Cadence	At Baseline and In 12 Weeks	The NUSHU shoes measure the cadence: number of strides per minute.
Mean Change from Baseline to Week 12 in Swing Phase	At Baseline and In 12 Weeks	The NUSHU Shoes measure the swing phase: ratio of swing time with respect to gait cycle duration.
Mean Change from Baseline to Week 12 in Stance Phase	At Baseline and In 12 Weeks	The NUSHU shoes measure the stance phase: ratio of stance time with respect to gait cycle duration.

Trial Locations

Locations (1)

Weill Cornell; 🇺🇸 New York, New York, United States